GF
APLS

Gabelli Funds’s Apellis Pharmaceuticals APLS Stock Holding History

Gabelli Funds’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-321,200
Closed -$12.9M – 1293
2026
Q1 		$12.9M Buy
+321,200
New +$6.92M 0.09% 273

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's APLS Position: Q2 2026 in Review

Gabelli Funds sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 321,200 shares — an estimated $12.9M sold.

Gabelli Funds first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $12.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Gabelli Funds reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Gabelli Funds sold 321,200 Apellis Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
  • Gabelli Funds first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Gabelli Funds's Apellis Pharmaceuticals position peaked at $12.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.